Skip to content
GLP-1 Scorecard
Menu
Site position #238

Alan Meds

By GLP-1 ScorecardUpdated

Alan Health, also known as Alan Meds, advertises compounded injection and sublingual options alongside branded prescription options.

Our take

Alan is a reasonable comparison if you want a choice of preparations and ongoing online care. We would settle the payment term and actual renewal-processing date first. Its lowest advertised equivalents require prepayment, and cancelling another charge does not recover unused treatment.

Visit Alan MedsWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$158/mo equivalent (2-month upfront promotion, compounded)
Tirzepatide
$325/mo equivalent (6-month upfront plan, compounded)
Coverage
Eligibility depends on state, prescription and pharmacy
Brand-name
Yes

Weigh Alan Meds against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Semaglutide advertises $158/month with two months paid upfront under a promotion; tirzepatide advertises $325/month with six months prepaid. These are advertised equivalents, not verified monthly card charges. Confirm the first payment, renewal amount and supplied quantity.

Start with the payment term

The semaglutide page pairs $158/month with a buy-one-month, get-one-free offer and two-month prepayment. Its separate $315 display does not settle your first charge or post-promotion renewal. Get those amounts before using our six-month cost guide to compare plans.

Tirzepatide's $325 starting label requires six-month prepayment. The advertised price stays the same across doses, but that does not establish monthly billing or your individual prescription. We would compare a shorter commitment before prepaying if you are still deciding whether the service suits you.

The $215/month oral offer also requires six months prepaid. The page describes sublingual compounded semaglutide dissolved under the tongue. It is a separate compounded preparation, not an FDA-approved oral product or evidence of the same outcomes as injections.

The renewal can arrive before the next treatment period

Alan's terms allow the first renewal to process up to five business days early. Cancellation must arrive at least three business days before renewal processing; partly used periods are not refundable. Confirm the actual processing date and set a reminder around it. Our cancellation guide separates avoiding the next debit from recovering an earlier one.

The Help page promises a full refund after clinical rejection. It also says an order cannot be cancelled once medical review has been submitted and processing begins, and prescription sales are final. Ask what happens to your payment at each stage.

Medical consent instead says all programs auto-renew with no refunds or exchanges. That broader statement needs reconciling with the rejection-refund promise if you depend on it. We cannot establish which document would control a dispute.

Confirm the preparation, not just the medication name

The semaglutide page discusses B12 and B6 additives. Request the exact ingredients and concentration rather than assuming the advertised preparation is what you will receive. The vial-label guide explains why concentration and syringe units need separate checks.

The tirzepatide page says preparations may include B6, B12, glycine and NAD+. This does not identify your ingredients or usable supply, or establish an extra clinical benefit from those additives.

Brand-name options need their own quote

The public catalog also lists branded Wegovy and Zepbound injections. Its product cards lead to clinical intake; they do not settle whether a selected price covers medication, care alone or both. Compare the pharmacy bill, care fee and testing separately before comparing a branded route with the compounded plans.

Separate the platform from the clinicians and compounder

Alan Health Technologies Inc., doing business as Alan Meds and Alan Health, is the stated platform operator. The site names MDI Medical Group P.C. and Alan Medical Group P.C. among independent physician networks and says Alan does not provide medical or pharmacy services. Ask who will actually prescribe and dispense for you.

The Help page permits a partner pharmacy or a licensed pharmacy of your choice, with outside-pharmacy charges paid separately. Use our pharmacy verification guide to check the named facility; a preferred pharmacy and the advertised bundle do not establish the same total cost.

Read the dated FDA record alongside current pharmacy information

FDA issued a February 20, 2026 warning letter to Alan Health Technologies Inc. dba Alan. Read that dated record alongside the current pharmacy information before deciding. We have not verified a later close-out or established the company's present regulatory status.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value72/100
Dose & formulation75/100
Clinical oversight55/100
Labs & monitoring53/100
Fulfillment78/100
Contract terms55/100

Strengths

  • Advertised compounded injection pricing stays the same across doses
  • Online care with a choice of injection and sublingual preparations
  • Outside-pharmacy choice described; separate charges may apply
  • Public catalog lists branded Wegovy and Zepbound options

What to consider

  • Lowest compounded price labels require upfront multi-month payment
  • First renewal may process early; cancel before the actual processing deadline
  • Unused subscription periods are not refundable under the ordinary terms
  • Rejection-refund promise differs from broader medical-consent wording

Bottom line — Grade C

Best for: Self-pay adults comfortable with online prescribing who can confirm eligibility, the treatment term and dispensing pharmacy before paying.

Look elsewhere if: Anyone needing monthly billing at the lowest headline, unused prepayment refunded, or an FDA-approved product from the compounded oral offer.

Site position #238 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to Alan Health Technologies Inc. dba Alan in February 2026. See the FDA warning-letter database.

Closest here

The rankings grading nearest Alan Meds — the realistic shortlist.

The 20 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Alan Meds's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Alan Meds's site. Not medical advice; see our disclosure.

← Back to the scorecard